ISTI LOGO
Towards a new dawn
×

img Acces sibility Controls

Research Projects Banner

Research Projects

Targeting nucleolin for refining anti-neoplastic chemo-immunotherapy and immunomodulation in B-Cell lymphoma

Implementing Organization

CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow
Principal Investigator
Dr Neeraj Jain
Scientist
|
CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow
CO-Principal Investigator
Dr Manisha Naithani
Scientist
|
CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow
CO-Principal Investigator
Dr Naveen Kumar Singhal
Scientist
|
CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow
CO-Principal Investigator
Dr Uttam Kumar Nath
Scientist
|
CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow
CO-Principal Investigator
Dr Gopal Chandra Kundu
Professor
|
Kalinga Institute of Industrial Technology
CO-Principal Investigator
Dr Anurag Varshey
Head
|
University of Patanjali

Project Overview

The study will understand in-depth functions of surface nucleolin in lymphoma biology, and this will determine alternative strategies to overcome chemotherapeutic resistance. The study will also analyses the importance of tumor cell specific surface nucleolin in maintaining stem cell phenotype and alternative strategies to target these cancer stem cell populations will be investigated.

Related Research

View All
Funding Organization
Funding Organization
Department of Science and Technology (DST)
Quick Information
Area of Research
Medical Sciences
Focus Area
Oncology
Start Year
2022
Sanction Amount
₹ 56.23 L
Status
Ongoing
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop